Clinical Trials Detail

Treating Patients With Stage IB-IIIA Non-Small Cell Lung Cancer After Surgery and Chemotherapy

Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-small Cell Lung Cancers

Objective
CategoryInformation
Study #:

EA5142 – Alchemist ANVIL

Anatomic Site: Lung
Histology: Non-Small Cell Lung Cancer (NSCLC)
Stage: Stage IB (with tumor size ≥4cm) - IIIA
Treatment Phase: Patients have undergone complete surgical resection of their cancer and have negative surgical margins, a baseline CT ensuring no evidence of disease, and registered to A151216.
Location:
Study Link: https://clinicaltrials.gov/ct2/show/NCT02595944?term=EA5142&rank=1

Clinical Trial Categories

  • Lung